We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cancer Victim: Monsanto’s Motion To Tax Trial Costs Should Be Denied

(November 6, 2018, 4:17 PM EST) -- SAN FRANCISCO — A cancer victim who accepted a reduced award of $78,506,418.35 in damages for exposure to glyphosate, the active ingredient in Monsanto Co.’s herbicide Roundup, on Nov. 2 filed...
To view the full article, register now.